Преподаватель с учёной степенью доктора SÜREYYA YİĞİT KAYA

ULUSLARARASI VE ULUSAL YAYINLAR:

 Yiğit Kaya S, Mutlu YG, Yücel OK, et al. Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients. Indian J Hematol Blood Transfus. 2025;41(1):38-42. doi:10.1007/s12288-024-01841-8

 Kadioglu T, Uzunlulu M, Yigit Kaya S, et al. Urinary kidney injury molecule-1 levels as a marker of early kidney injury in hypertensive patients. Minerva Urol Nefrol. 2016;68(5):456-461.

 Kilic Gunes E, Yigit Kaya S, Yaman F, et al. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience. Leuk Res. 2024;140:107484. doi:10.1016/j.leukres.2024.107484

 Yiğit Kaya S, Mutlu YG, Malkan ÜY, et al. Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience. Leuk Res. 2024;140:107495. doi:10.1016/j.leukres.2024.107495

 Mutlu YG, Uzunabdullah E, Yahya D, et al. Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience. J Clin Med. 2026;15(2):453. Published 2026 Jan 7. doi:10.3390/jcm15020453

 Yiğit Kaya S, Kaynar L, Mutlu YG, et al. Myth or reality: Graft versus host disease after autologous hematopoietic cell transplantation, a multicentre experience. Transpl Immunol. 2025;93:102286. doi:10.1016/j.trim.2025.102286

 Atas U, Iltar U, Yucel OK, et al. Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin. J Clin Med. 2025;14(20):7294. Published 2025 Oct 16. doi:10.3390/jcm14207294

 Isleyen E, Alhan N, Terzi Demirsoy E, et al. Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group. J Clin Med. 2025;14(19):6813. Published 2025 Sep 26. doi:10.3390/jcm14196813

 Mutlu YG, Emre Ünsal Ş, Güleç B, et al. The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History. Clin Lymphoma Myeloma Leuk. 2026;26(2):e248-e253. doi:10.1016/j.clml.2025.10.006

 Kilic Gunes, E., Yavasoglu, F., Kucukyurt, S. et al. Treatment Outcomes of Elderly Patients with Mantle Cell Lymphoma: A Multi-center Real-World Data. Indian J Hematol Blood Transfus 42, 82–92 (2026). https://doi.org/10.1007/s12288-025-01979-z

 Karakus V, Pinar IE, Iltar U, et al. Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry. J Clin Med. 2025;14(20):7367. Published 2025 Oct 18. doi:10.3390/jcm14207367

 Kars TU, Göker H, Demiroğlu H, Malkan ÜY, Aladağ Karakulak E, Erdekli FT, Deveci B, Yiğit Kaya S, Kaynar L, Dikyar A, et al. Direct Second Autologous Stem Cell Transplantation Versus Re-Induction Followed by Transplantation in Relapsed Multiple Myeloma: A Multicenter Real-World Study. Journal of Clinical Medicine. 2026; 15(13):5045. https://doi.org/10.3390/jcm15135045

 Yiğit Kaya S, Vatani M, Maral S, Beköz HS, Abedi AH, Çınar OE, Oluk B, Kaynar L. A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen. Journal of Clinical Medicine. 2026; 15(14):5401. https://doi.org/10.3390/jcm15145401

 Yiğit Kaya S, Kadıoğlu T, Uzunlulu M, Oğuz A, İşbilen Başok B. Urinary Neutrophil Gelatinase-Associated Lipocalin Levels as an Indicator of Early Kidney Injury in Patients with Type 2 Diabetes Mellitus. Lokman Hekim Health Sci 2024;4(1):14–19. DOI: 10.14744/lhhs.2023.5001

 Ayhan Z, Kaya SY, Ozcan MA, Saatci AO. Brentuximab vedotin related bilateral Purtscher-like retinopathy unresponsive to pulse steroid therapy and intravitreal aflibercept injection. GMS Ophthalmol Cases. 2017;7:Doc29. Published 2017 Dec 15. doi:10.3205/oc000080

 Yiğit Kaya S, Askin AE, Bektas S, Çakır A, Gökmen Sevindik Ö. Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder. Leuk Res Rep. 2023;19:100369. Published 2023 May 4. doi:10.1016/j.lrr.2023.100369

 Mutlu YG, Yıgıt Kaya S, Maral S, Melek E, Baslar Z, Kaynar L and Sevindik OG (2023) Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case. Front. Immunol. 14:1276295. doi: 10.3389/fimmu.2023.1276295

 Özalp, Y.C., Shehabie, H., Tekin, M.G. et al. Atypical presentation of PJP: hypercalcemia and kidney injury in an allogeneic stem cell transplant recipient. BMC Infect Dis 24, 1201 (2024). https://doi.org/10.1186/s12879-024-10074-z

 Yiğit Kaya, S., Vatani, M., Akil, R. et al. A complete response with daratumumab, venetoclax, azacitidine and dexamethasone in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic leukemia/lymphoma patient. Ann Hematol 104, 829–833 (2025). https://doi.org/10.1007/s00277-024-06118-8

 Yahya, D., Ayran, M., Özden, F. et al. Successful treatment of steroid-refractory gastrointestinal GVHD with ruxolitinib in a patient after autologous stem cell transplantation: a case report. Int J Hematol 122, 927–931 (2025). https://doi.org/10.1007/s12185-025-04073-2

 Yunus Can Ozalp, Senem Maral, Sureyya Yigit Kaya, Huseyin Saffet Bekoz, Leylagul Kaynar, Cutaneous cytomegalovirus infection: a case report, Skin Health and Disease, 2026;, vzaf057, https://doi.org/10.1093/skinhd/vzaf057

 Yiğit Kaya, S., Bektas, S., Askin, A.E. et al. Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient. Ann Hematol 102, 1599–1600 (2023). https://doi.org/10.1007/s00277-023-05231-4

 Yiğit Kaya S, Akil R, Akyol G, Abedi AH, Çelik S, Kaynar L. Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma. Turk J Haematol. 2026;43(1):91-92. doi:10.4274/tjh.galenos.2025.2025.0252

 Yiğit Kaya, S., Melek, E., Mutlu, Y.G. et al. When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma. Ann Hematol 104, 2079–2080 (2025). https://doi.org/10.1007/s00277-025-06285-2

 Akil, R., Yiğit Kaya, S., Beköz, H. S., Çakır, A., & Kaynar, L. (2026). Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report. Turk J Hematol, 0(0), 0-0. https://doi.org/10.4274/tjh.galenos.2026.13284.

 Güven S, Yavuz B, Erdoğan E, Karatas A, Özsan G, Demirkan F, Ündar B, Özcan M, Kiper D, Çetintepe T, Göçer M, Kurtoğlu E, Balık B, Sevindik Ö, Kaya S, Alacacıoğlu İ Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis. Eurasian Journal of Medicine and Oncology. 2023; 7(1): 49 - 56. 10.14744/ejmo.2023.64688

 Yiğit Kaya S, Maral S, Abedi AH, Beköz HS, Kaynar L. Venetoclax-based treatment in adult relapsed/refractory acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center real-world experience. J Health Sci Med / JHSM. 2026;9(1):140-146. doi:10.32322/jhsm.1825832

 F. Özdemirkıran, Serife Solmaz Medeni, Füsun Özdemirkıran, K. B. Payzın, Kadriye Bahriye Payzın, Ö. G. Sevindik, C. Acar, Ömür Gökmen Sevindik, Celal Acar, D. Türkyılmaz, Doğuş Türkyılmaz, S. Yiğit Kaya, İ. Alacacıoğlu, Süreyya Yiğit Kaya, Ö. Pişkin, İnci Alacacıoğlu, F. Demirkan, Özden Pişkin, H. G. Özsan, Fatih Demirkan, Hayri Güner Özsan, M. A. Özcan, Mehmet Ali Özcan. Paroksismal Nokturnal Hemoglobinürili Olguların Değerlendirilmesi: İki Merkezin Deneyimi. DEU Tıp Derg. 01 Aralık 2014;28(3):139-43. doi:10.18614/deutfd.40684

 Sevindik, Ö. G., Acar, C., Türkyılmaz, D., Kaya, S. Y., Alacacıoğlu, İ., Pişkin, Ö., Özcan, M. A., Demirkan, F., & Özsan, H. G. (2015). Retrospectıve Evaluatıon Of Patıents Treated Wıth Double Fıltratıon Plasmapheresıs. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi, 19(4), 181-185. https://izlik.org/JA23BZ27JW

 Şerife Solmaz Medeni, Ömür Gökmen Sevindik, Celal Acar, Doğuş Türkyılmaz, Süreyya Yiğit Kaya, Sunay Tunalı, İnci Alacacıoğlu, Özden Pişkin, Fatih Demirkan, Güner Hayri Özsan, Mehmet Ali Özcan, Bülent Ündar. Akut Myeloid Lösemi Hastalarımızın Retrospektif Değerlendirilmesi. DEU Tıp Derg [Internet]. 01 Aralık 1899;29(2):65-9. Erişim adresi: https://izlik.org/JA55JG52NP

 Kaya, Sureyya Yigit, et al. "Belinostat in relapsed/refractory peripheral T-cell lymphoma: A real-world multicenter experience." Annals of Medical Research 33.4 (2026): 178-184. https://www.annalsmedres.org/index.php/aomr/article/view/4910

 Yiğit Kaya, S. (2023). Recurrent Herpes Infection in Two Cases with Chronic Myeloid Leukemia Using Dasatinib. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 10(1), 65-66. https://doi.org/10.47572/muskutd.1015154

KİTAPLAR VE KİTAP ÇEVİRİLERİ:

 KAYA, Süreyya YİĞİT, and Güner Hayri ÖZSAN. "AL Amiloidoz." Turkiye Klinikleri Hematology-Special Topics 11.2 (2018): 140-146.

 Kaya, S. Y. (2025). Yaşlı hastada akut lenfoblastik lösemi yönetimi.

N. A. Soyer, S. Savaş, & F. Şahin (Ed.), Yaşlı hastada malign hematolojik hastalıklara yaklaşım (s.23-29). US Akademi.

 Kaya, S. Y. (2023). Vitamin B12 ve folik asit eksikliği anemisi.

D. Çekiç & K. İşsever (Ed.), Genel dahiliyede güncel konular (s. 15-24). Livre de Lyon.

 Kaya SY, Sevindik ÖG. Monoclonal gammopathy of undetermined significance, diagnosis, clinical impact and management.

In: Sevindik ÖG, editor. Multiple myeloma and other plasma cell dyscrasias. Ankara: Türkiye Klinikleri; 2025. p.1-8.

 Kaya, S. Y. (2025). Marjinal zon lenfoma.

G. Pektaş (Ed.), Hematolojik hastalıkların fizyopatolojik temelleri (2. cilt, s. 183-187). Holistence Publications.

 Kaya SY. Anemi gelişen kronik böbrek hastasında hematoloji konsültasyonunda dikkat edilmesi gereken noktalar nelerdir?

In: Erişkin hematolojisinde pratik konsültasyon yaklaşımları. Ankara: Hematoloji Uzmanlık Derneği; 2024. s. 70-73.

 Lichtman MA, Kaushansky K, Prchal JT, Levi MM, Burns LJ, Linch DC. Williams Hematoloji El Kitabı. 10. baskı. Tombak A, çeviri editörü. İstanbul: İstanbul Tıp Kitabevi; Yıl. Bölüm 17. Kararsız hemoglobinler ve değişmiş oksijen afiniteli hemoglobinler.